Hot Pursuit     20-Jun-14
Orchid Chemicals jumps on USFDA nod for a medicine
Orchid Chemicals & Pharmaceuticals surged 6.12% to Rs 76.25 at 9:17 IST on BSE after the company said it has received approval from USFDA for its abbreviated new drug application for Eszopiclone tablets, 1 mg, 2 mg, and 3 mg strengths.

The announcement was made after market hours on Thursday, 19 June 2014.

Meanwhile, the S&P BSE Sensex was up 26.65 points or 0.11% at 25,228.45.

On BSE, so far 1.47 lakh shares were traded in the counter as against average daily volume of 7.97 lakh shares in the past two weeks.

The stock hit a high of Rs 76.80 and a low of Rs 75.10 so far during the day.

Orchid Chemicals & Pharmaceuticals reported a net loss of Rs 80.79 crore in the quarter ended 31 March 2014, lower than net loss of Rs 132.27 crore in the quarter ended 31 March 2013. Net sales rose 67.2% to Rs 448.46 crore in the quarter ended 31 March 2014 over the quarter ended 31 March 2013.

Orchid Chemicals & Pharmaceuticals is involved in the development, manufacture and marketing of diverse bulk activities, formulations and nutraceuticals.

Previous News
  Broader mkt underperforms; metal stocks lose shine
 ( Market Commentary - Mid-Session 23-Jun-23   11:35 )
  Orchid Pharma announces board meeting date
 ( Corporate News - 05-Feb-24   12:30 )
  Orchid Pharma to announce Quarterly Result
 ( Corporate News - 30-Oct-23   19:26 )
  Orchid Pharma converts Rupee term loan into Foreign Currency term loan
 ( Corporate News - 07-Dec-21   18:40 )
  Orchid Pharma schedules board meeting
 ( Corporate News - 09-Nov-21   17:12 )
  Orchid Pharma hits the roof on launching QIP issue
 ( Hot Pursuit - 23-Jun-23   11:26 )
  Orchid Pharma spurts after securing EIR for unit
 ( Hot Pursuit - 18-Apr-17   14:39 )
  Orchid Pharma launches QIP issue
 ( Corporate News - 23-Jun-23   10:12 )
  Orchid Pharma to hold AGM
 ( Corporate News - 07-Dec-20   12:03 )
  Orchid Pharma reports standalone net loss of Rs 60.98 crore in the December 2016 quarter
 ( Results - Announcements 07-Feb-17   17:06 )
  Orchid Pharma receives EIR report for API facility in Alathur, Tamil Nadu
 ( Corporate News - 21-Sep-17   13:33 )
Other Stories
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
Back Top